Inventor

SNOW ALAN D

US58 patents

⚠️ This page may combine multiple inventors who share the name “SNOW ALAN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SNOW ALAN D

UNIV WASHINGTON

Rodent models of human amyloidoses

Specific saccharide compositions and methods for treating Alzheimer&#39;s disease and other amyloidoses

Composition and methods for treating Alzheimer&#39;s disease and other amyloidoses

Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer&#39;s Disease and other amyloidoses

Composition and methods for inhibiting the formation of brain amyloid deposits

Compositions for treating alzheimer&#39;s disease and other amyloidoses

Diagnostic applications of perlecan domain I splice variants

Peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses

Therapeutic applications of laminin and laminin-derived protein fragments

Peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer&#39;s disease and other β-amyloid protein fibrillogenesis disorders

In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer&#39;s and Prion diseases

Methods for producing pure perlecan and other heparan sulfate proteoglycans

Methods of isolation of amyloid inhibitory ingredients within Uncaria tomentosa

Methods for using specific saccharides for treating alzheimer&#39;s disease and other amyloidoses

PROTEOTECH INC

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer&#39;s disease, type 2 diabetes, and parkinson&#39;s disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer&#39;s disease, type 2 diabetes, and parkinson&#39;s disease

Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis

Use of compounds and compositions for the treatment of amyloid diseases

Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants

Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies

Composition and methods for treating Alzheimer&#39;s disease and other amyloidoses

Screening assay for macromolecules that inhibit binding of sulfated glycosaminoglycan to beta amyloid

Methods of treating Alzheimer&#39;s disease and other amyloidoses using Hypericum perforatum and derivatives thereof

Small peptides for the treatment of alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Substituted N-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies

Small peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein disorders

Compounds for the treatment of neurodegenerative diseases

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer&#39;s disease, type 2 diabetes, and Parkinson&#39;s disease

Compounds, compositions, and methods for the treatment of synucleinopathies

SNOW ALAN D

Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer&#39;s disease, type 2 diabetes and Parkinson&#39;s disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer&#39;s disease, type 2 diabetes and parkinson&#39;s disease

Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer&#39;s disease, type 2 diabetes, and parkinson&#39;s

Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases

CASTILLO GERARDO

Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants

Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants

Methods for using glucose pentasulfate for treating amyloid associated with type II diabetes

COGNITIVE CLARITY INC

Compositions and methods for the treatment of plaques and tangles in humans and animals

Compositions and methods for the treatment of plaques and tangles in humans and animals

Compositions and methods for the treatment of “plaques and tangles” in humans and animals

CASTILLO GERARDO M

Small peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

Small peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

UNIV WASHINGTON TECH TRANSFER

Animal models of human amyloidoses

(unassigned)

Peptides for the treatment of Alzheimer&#39;s disease and other beta-amyloid protein fibrillogenesis disorders

MARESH GRACE

Therapeutic and diagnostic applications of perlecan domain I splice variants

ESPOSITO LUKE A

Compounds for the treatment of neurodegenerative diseases

Specific saccharide compositions and methods for treating Alzheimer's disease and other amyloidoses

Composition and methods for treating Alzheimer's disease and other amyloidoses

Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer's Disease and other amyloidoses

Compositions for treating alzheimer's disease and other amyloidoses

Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer's disease and other β-amyloid protein fibrillogenesis disorders

In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases

Methods for using specific saccharides for treating alzheimer's disease and other amyloidoses

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

Composition and methods for treating Alzheimer's disease and other amyloidoses

Methods of treating Alzheimer's disease and other amyloidoses using Hypericum perforatum and derivatives thereof

Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein disorders

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's

Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders